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Thepurpose ofthestudywas tomeasure riskofchildhoodacutelymphoblasticleukemiaassociat-
edwith reported postnatal diagostic X rays and to determine ifit was modified in the presence
of variants in genes involved i:n DNA repair. We conducted a population-based case-control
studywith 491 cases and 491 healthycontrols among children 0-9 years ofage at diagnosis. To
evaluategene-environment interaction, we used asubgroup of129 cases. Tlheadjusted odds ratio
(OR) for one reported postnatal childXrayversus nonewas 1.04 [95% confidence intervl (CI),
0.72-1.49], whereas the OR for two or more X rays was 1.61 (CI, 1.13-2.28). Amonggirls, the
former ORs were 1.14 (CI, 0.66-1.96) and 2.26 (1.204.23), respectvely. Amonggirls who car-
ried the bMSH3 [exon (ex) 23] variant, the ORs were 3.33 (CI, 0.75-14.82) for one X ray and
0.27 (CI, 0.05-1.57) fortwo or moreXrays,whereas amongthose who carriedtheXRCCI(e 6)
variant, the ORs were 1.45 (0.11-19.08) and6.66 (0.78-56.63), respectively. Ontheotherhand,
at low levels ofexposure, boys seemed protected by thevariant bMLHI (a 8). The latter results
must be interpreted with caution but suggest that the effect ofdiagnostic X rays could be modi-
fied by variants in repair genes according to sex Few studies have evaluated the risk ofpostnatal
diagnostic irradiation, which was moderately strong here; we are not aware ofany studies that
also considered the effect ofpolymorphisms in DNA repair genes. Based on the present results,
both aspects deserve fiuther study. Key word childhood leukemia, diagostic irradiation, DNA
repair genes, gene-environment interaction, polymorphisms. Environ Health Perspect
108:495498 (2000). [Online 12April2000]
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Prenatal diagnostic irradiation is a recognized
risk factor for childhood cancer (1), but the
risk associated with postnatal diagnostic irra-
diation is not well established. Excluding
studies where children received radiation as a
treatment, we found only a few studies that
considered postnatal diagnostic X rays as a
risk factor for childhood leukemia (2-8);
however, their results are consistent in that
reported exposure in cases was almost always
more frequent than in controls.
Reduced DNA repair capacity may
increase susceptibility to breast and lung
cancers (9,10) as well as to hematologic
malignancies. For instance, the development
of leukemia and lymphoma in cases of
Fanconi anemia or ataxia telangiectasia is
associated with defective DNA repair
(11,12). Therefore, DNA repair genes may
play a key role in tumor development and in
radiosensitivity. Recently, common variants
were identified at the coding sequence of
XRCC1 (13), a gene involved in the base
excision repair (14), as well as in the DNA
mismatch repair genes hMLHJ and hMSH3
(15). Although the significance ofthese vari-
ants is not completely dear at this time (16),
it is plausible that they would be associated
with altered DNA repair capacity and with
modified susceptibility to cancer. We can
then hypothesize that postnatal irradiation in
a child with certain forms of DNA repair
genes would be at increased riskofcancer.
The objectives of this study were to
measure the effect ofreported postnatal diag-
nostic irradiation on childhood acute lym-
phoblastic leukemia (ALL) and to carry out a
preliminary study to assess whether this effect
seems modified by DNArepair genevariants.
Materials and Methods
Gaseascertainment. The study methods have
been described by Infante-Rivard et al. (17).
Cases diagnosed between 1980 and 1993 in
the province of Quebec (Canada) and aged
between 0 and 9 years were recruited from
tertiary care centers designated by govern-
ment policy to treat and hospitalize children
in the province with cancer. Tracing cases
from these hospitals is equivalent to apopula-
tion-based ascertainment. Forfeasibility (cost)
reasons, children living in the less populated
and the most distant regions from urban cen-
ters were not induded in the study. Based on
population denominators, the regions not
studied would indude approximately 10% of
theprovincial population. Forsimilar reasons,
from 1991 to 1993, only cases from the
Metropolitan Montreal region (approximately
60% of the provincial population) were
included in the study. Because cancer care is
covered under the universal health plan, we
believethatanegligible numberofchildren, if
any, were treatedoutside the province.
A case [International Classification of
Diseases, 9th Revision (World Health Organ-
ization, Geneva) coding 204.0] was deter-
mined to have ALL on the basis of clinical
andbiologicstandard criteriabyan oncologist
or a hematologist in a tertiary care center. To
identify cases, we used: a) hospitalization data
from the provincial government's computer-
izeddischargedatafiles; b) hospitalization cen-
suses fromtherespectivehospitals (wechecked
all medical records with a relevant discharge
diagnosis); c) lists maintained by hematol-
ogy-oncology laboratories ofhistologic data
for cases; and 4) outpatient oncology records
from the largest pediatric center in the
province (HopitalSaint-Justine, Montrdal).
Control ascertainment. Population-based
controls (one per case) were matched on age
(within 24 months), sex, and region of
residence at the time of diagnosis. These
regions are based on administrative and geo-
graphic criteria determined by the govern-
ment and they cover a wide territory. The
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population-based controls were chosen from
family allowance files. The family allowance
is a government stipend which, at the time
ofthe study, was awarded to all legal resident
families with children in Canada. According
to the expected distribution of cases based
on matching criteria, we randomly chose a
list of 10 potential controls from the family
allowance files.
Children who were adopted, lived in fos-
ter families, whose family spoke neither
French norEnglish, orlived outofthe coun-
try were considered ineligible. We also did
not consider children whose mother was in
prolonged psychiatric treatment, or whose
parents were both unavailable. We identified
510 eligible cases and interviewed 491 par-
ents (96.3%); 588 eligible controls were
recruited and 493 (83.8%) parents partici-
pated. Among controls, 74 children were the
second control on the list ofeligibles, 9 were
the third choice, and 1 was the fourth. The
others were first choices on the list ofeligi-
bles. Reasons for nonparticipation were a
confidential telephone number, refusal, or a
nontraceable family. Two strata without
cases were ultimately rejected, leaving 491
cases to be used in the analysis and 491
healthypopulation controls.
Data collection. Permission to access
cases was granted by the institutional review
board ofeach hospital; permission to access
controls was granted by the provincial
agency regulating access to public databases
with nominal information. Soon after the
anticipated reception ofa letter introducing
the general purpose of the study, trained
interviewers contacted the parents to sched-
ule an appointment for the interview, which
was administered by telephone using a struc-
tured questionnaire. Questionnaires were
reviewed as were completed and feedback
was regularlyprovided to interviewers.
The questionnaire included information
on possible confounding variables as well as
on diagnostic irradiation. Mothers were asked
about specific X rays during pregnancy, such
as pelvimetry and abdominal X rays. The
mothers also answered questions about the
nature and number ofX rays for the study
child after birth. For instance, we asked, "has
your child ever had a pulmonary X ray?"; if
the answerwasyes, weaskedhowmanytimes
he or she had such an exam, atwhat age, and
if it was for diagnostic or routine purposes.
Pelvimetries and children's X rays are
described asthetotal numberreported.
Data analysis. We used conditional
logistic regression to estimate odds ratios
(OR) and95% confidence intervals (CIs). In
addition to the matching variables, the OR
were adjusted for maternal age and level of
schooling, pelvimetries, and abdominal X
rays and diseases duringpregnancy.
We evaluated the linear component of
the trend for the number of the child's X
rays by reparameterizing the categories for
the number of X rays and introducing a
single variable in the model. We assessed
departure from linearity by comparing the
log-likelihood ofa model where the variable
is entered as asingle parameterwith that ofa
model where the single parameter is present
as well as the square of this parameter (a
quadratic term) (18).
Case-onlystudy. To circumvent theprac-
tical and ethical problems associated with
taking blood from normal controls (children
posing an added difficulty), several authors
have proposed the use of case-only studies,
where cases with the genotype at risk (defin-
ing carriers of specific mutations) are com-
pared to cases without the given mutation
with respect to exposure (19-21). This
approach will not allowthe direct estimation
ofthe effect ofthe exposure nor ofthe geno-
type on risk but will allow the estimation of
the interaction effect between exposure and
the mutation. One ofthe advantages ofthis
design is that it is moreefficient than the tra-
ditional case-control approach to estimate
the interaction parameter. The validity of
this design to estimate the interaction OR
depends on the assumption that amongcon-
trols, genotype and exposure are indepen-
dent, i.e., the fact of having the mutation
will not influence theexposure.
Genotyping. A sample of 129 cases from
the Hopital Sainte-Justine and which were
part of our case-control study had already
been genotyped (22). All of the parents
accepted our use of DNA material that was
already provided for diagnostic and thera-
peutic purposes. We used a polymerase
chain reaction (PCR)/allele-specific-oligonu-
deotide (ASO) hybridization assay to geno-
type four allelic variants in three DNA repair
genes: exon 6 ofXRCCI (Arg-to-Trp substi-
tution at codon 194), exon 8 of hMLHI
(Ile-to-Val substitution at codon 219), exon
21 of hMSH3 (Arg-to-Glu change at codon
940), and exon 23 of hMSH3 (Thr-to-Ala
modification at codon 1036). With this
method,ASOs complementary to each ofthe
variants distinguishing between the mutant
and the normal alleles are used as probes to
hybridize dot-blots containing PCRproducts
(23). We extracted genomic DNA from cells
derived either from mouth epithelium,
peripheral blood, or bone marrow in remis-
sion, aspreviouslydescribed (24).
Because we studied inherited polymor-
phisms rather than somatic mutations, the
genetic integrity of the samples after treat-
ments should not be ofconcern. We studied
mutations that are unique and established in
human populations, where they were pre-
sumably introduced as a result of a single
mutation event. The probability that such
an event may recur during cancer develop-
ment and/or treatment is negligible.
Data analysis. For the case-only study,
we used unconditional logistic regression to
estimate the interaction ORs and their CIs,
adjustingforage andsexofthe child.
Results
Case-control study. The case and control
groups each induded 216 girls and 275 boys.
Fifteen cases were younger than 1 year ofage
(3%); 64 cases were younger than 2 years of
age (13%), and 249 cases were younger than
4 years ofage (51%). In the majority ofpairs
(i.e., 465 of491), the age difference between
case and control was < 3 months; for other
pairs, the difference rangedbetween 3 and 12
months or more. Other descriptive data for
cases and controls are shown in Table 1;
slighdy more case than control mothers were
in the higher age group and in the lower lev-
els ofschooling. More postnatal X rays were
reportedforcases than forcontrols.
Analyzing the relation between postnatal
X rays and the incidence ofALL without
controlling for additional variables than the
matching factors, the results were as follows:
one reported child X ray (versus none) was
associated with an OR of 1.01 (CI,
0.71-1.45) and two or more X rays with an
ORof1.60 (CI, 1.13-2.24).
Results for child's X rays adjusted for pre-
natal X rays (pelvimetry and abdominal X
rays), maternal age, and level ofschooling
were as follows: one X ray, OR = 1.04 (CI,
0.72-1.49) and two or more X rays, OR =
1.61 (CI, 1.13-2.28). The latter ORs did not
materially change when also adjusting for
maternal pregnancy diseases. When excluding
Table 1. Sociodemographic, pregnancy, and diag-
nostic X-rayvariablesfor cases and controls.
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the infants younger than 1 year of age, the
ORs remained almost identical; i.e., 1.06
(CI, 0.74-1.52) and 1.62 (CI, 1.14-2.30)
forone and two ormoreXrays, respectively.
There was no statistically significant
departure from linearity in the relation
between the number of the child's X rays
andALL; thechange in ORforeach increase
in the level ofchild's X rays was 1.25 (CI,
1.06-1.49).
To account for latency, we excluded the
Xrays received 1 or3 months before the date
ofdiagnosis; 8 cases and 11 controls had an
X ray in the month before the date ofdiag-
nosis, whereas 26 cases and 19 controls had
one in the 3 months before the diagnosis.
The adjusted ORfor oneXraywhen remov-
ing thoseXrays received in the month before
the diagnosis was 1.07 (CI, 0.74-1.56),
whereas that for two ormoreXrayswas 1.85
(CI, 1.28-2.69). Removal of the X rays in
the 3 months before the diagnosis resulted in
ORs of 1.08 (CI, 0.73-1.59) and 1.78 (CI,
1.21-2.63) for one and two or more X rays,
respectively.
The nature ofX rays was very similar in
both groups, as most were bone X rays;
almost all procedures in both groups were to
establish adiagnosis.
Finally, we estimated the risk ofALL for
child's X rays stratifying on sex (Table 2);
fewer girls than boys had received X rays. In
addition, there was a smaller percentage of
girls who had received two or more X rays.
The risk ofALL was somewhat more elevat-
edforgirls.
Case-only study. Results from the geno-
typed cases are shown in Table 3. A maxi-
mum of 129 cases was available for these
analyses. Results show that when all of the
genotyped group was considered together.
the variant hMLHJ [exon (ex) 8] conferred
protection at low level ofexposure, whereas
the variant hMSH3 (ex 23) was associated
with an increased risk at the same level of
exposure. The variants hMLHI (ex 8) and
hMSH3 (ex 21) modified the risk among
boys at low level ofexposure (the first vari-
ant was protective and the second increased
risk); among girls, risk was increased with
the variants hMSH3 (ex 23) and XRCCI (ex
6) (at low level for the first variant and at
high level forthesecond).
Table 2. Adjusted ORs' and CIs for the associa-
tion of child's postnatal diagnostic X raysb and
ALL by sex.
X rays Girls Boys
(n) No. OR(Cl) No. OR(Cl)
None 275 1.00 295 1.00
1 73 1.14(0.66-1.96) 109 0.94(0.56-1.55)
>2 68 2.26(1.20-4.23) 133 1.39(0.91-2.14)
aAdjusted for maternal age and maternal level of school-
Discussion
The effectofreceiving more than two postna-
talX rays was associatedwith asignificant and
moderately elevated risk ofALL. Although
consistent with the results ofprevious studies
(2-8), the question ofdifferential parental
recall remains a concern in case-control stud-
ies. We carried out a validation substudy for
prenatalX rayswith the presentdata, compar-
ing reported X rays (ofany type except dental
Xrays) with those found in the maternal hos-
pital medical record (25). We also reviewed
studies on parental recall incase-control stud-
ies ofadverse pregnancy outcomes and chron-
ic childhood diseases. Our results show that
both case and control mothers underreported
prenatal X rays in a relatively similar manner
(64% sensitivity in cases and 71% in con-
trols). This condusion is alsoapplicable to the
majority ofstudies reviewed. Thus, although
underreporting seems a frequent problem,
important differences in recall were rarely
observed, and if so, they were mainly under
the circumstances of possible clusters with
publicized potential risk factors. Of course,
thesefindingsdo not guarantee theabsenceof
differential recall for child X rays in the pre-
sent study, but the presence ofsuch a bias
cannotbeautomaticallyassumed.
Removing the X rays taken close to the
time ofdiagnosis did not materially alter the
results. However, the notion of latency in
childhood leukemia is not defined and these
timeperiods werearbitrarily chosen.
The data suggest that the effect ofpostna-
tal diagnostic irradiation may be more pro-
nounced among girls. Explanations for the
results by sex are not readilyavailable. Studies
ofprenatal paternal irradiation in mice (mat-
ing with a nonirradiated female) show an
increase in the incidence of leukemia in
females (26). In addition, recent analyses
from atomic bomb survivors exposed in utero
and as children younger than 6 years of age
suggest a similar observation: although there
were only 10 cancer deaths among those
exposed in utero (n = 807), 9 occurred in
females (24). Finally, females irradiated for
retinoblastoma also seem at greater risk of a
second cancer (28). Although these risk situ-
ations are quite different from the situation
in the present study, they may nevertheless
indicate a form ofsusceptibility to ionizing
radiation forfemalechildren.
Radiation doses to children from com-
mon X rays show substantial variations
between hospitals within the same time peri-
od andgeographic territory (29-34). Factors
such as changes in technical staffwithin the
same radiologic unit, whether the unit is in a
specialized or a general center, the age ofX-
ray generators, the body size of the child,
and other more technical aspects related to
the procedure itself affect the dosage.
Unfortunately we have no dose estimation
for theX rays received bythe children in this
study. X rays were administered in centers all
over the province, from specialized to gener-
al, over a period of > 20 years (from 1970 to
1993; cases entered the study between 0 and
9 years of age between 1980 and 1993).
Dose variability information from the litera-
ture and the conditions ofX-ray administra-
tion in this study indicate that doses were
likely to be quite variable. These observa-
tions are unlikely to explain our results
because it is probable that doses were the
same for cases and controls. However, they
are useful to draw attention to the fact that
controlofdosagedoes not seemfullyachieved
for pediatric diagnostic irradiation, leaving a
potential for doses that are not optimal.
Children may be receiving radiation athigher
doses than previouslybelieved at an agewhere
they are moresusceptible to radiation.
Overall, our preliminary results on
gene-environment interaction suggested the
following observations: risks maybe increased
or decreased by the variants; risks do not
necessarily increase with higher level of expo-
sure; and finally, some variants modify risks
in girls and others in boys. Most results were
estimated with large confidence intervals and
must be interpreted with caution because
chance could still be an explanation for the
findings. Nevertheless, we believe that the
present results are plausible, given previous
Table 3. Case-only interaction ORs and CIs between DNA repair gene polymorphisms and reported expo-
sureto postnatal diagnostic X rays.
X rays(n), hMLHl(ex8)
sex(n) (n= 129)
DNA repair gene variants




oa 1.00 1.00 1.00 1.00
1a 0.33(0.13-0.84) 1.42(0.52-3.83) 1.71 (0.68-4.26) 1.16(0.30-4.38)
>2a 0.97 (0.39-2.36) 0.97(0.36-2.60) 0.71 (0.29-1.73) 1.06(0.32-3.54)
lb
Boys 0.26(0.07-0.87); n=79 2.95(0.75-11.03); n= 75 1.07(0.31-3.63); n=71 1.05(0.21-5.12); n= 66
Girls 0.49(0.11-2.11); n= 50 0.42(0.07-2.48); n=47 3.33(0.75-14.82); n=54 1.45(0.11-19.08); n=44
22b
Boys 0.76(0.26-2.25); n= 79 1.79(0.50-6.42); n=75 0.99(0.33-2.96); n= 71 0.44(0.09-2.07); n= 66
Girls 1.58(0.30-8.24); n= 50 0.42(0.07-2.48); n=47 0.27(0.05-1.57); n= 54 6.66(0.78-56.63); n= 44
ORs adjusted forage and sexofthe child. 6Adjusted for age ofthe child.
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observations from adult cancer studies, and
should provide an incentive for further stud-
ies. Variants can protect against risk or
increase risk (35). Also, some authors have
suggested (36,37) that the role of variants
could be more marked at low levels ofexpo-
sure than at high levels because at high levels
the metabolic pathways could already be over-
whelmed regardless of the presence ofvari-
ants. Finally, in one ofthe only studies carried
out on the riskofALL in relation to polymor-
phisms in genes encoding enzymes involved
in the metabolism of xenobiotics (22), we
observed that the risk associated with carrying
at least one CYPlAJ*4allele was significantly
protective in girls (OR = 0.2; CI, 0.05-0.9),
whereas it increased in boys (OR = 1.48).
These observations underscore the complexi-
ty ofinteractions between personal and expo-
sure characteristics and gene polymorphisms.
For this reason, the present results should be
interpreted as a first step in the description of
some gene-environment interactions in
childhood ALL.
The assumption required for the validity
ofthe interaction OR in the case-only study
(independence of exposure and genotype in
the population) was not directly checked but
it seems unlikely that it would be violated.
Violation ofthe assumption could imply, for
instance, that healthy children with variants
would stayaway from diagnostic X rays.
Genes involved in DNA repair are critical
for maintaining the integrity ofgenetic mate-
rial transmitted from one cell to another and
for protection against mutations leading to
cancer. Mammalian cells rely on DNA repair
systems to maintain their genomic integrity.
Genes involved in the repair ofdouble-strand
DNA breaks (such as XRCC1) (38) that can
be induced byX rays and other ionizing radi-
ation, are especially relevant to cancer risk.
XRCCJ-linked polymorphism was associated
with cancer in radiosensitive patients (39).
This observation is supported by the exis-
tence ofrare human disease syndromes asso-
ciated with pronounced cellular sensitivity to
DNA-damaging agents that arise from defi-
ciencies in DNA repairs. Such instability syn-
dromes (e.g., xeroderma pigmentosum, ataxia
telangiectasia, Bloom syndrome, and Fanconi
anemia) show marked predisposition for
hematologic malignancies. The expression of
the hMSH3 gene, a component of the mis-
match repair machinery (40Q, is significantly
decreased in patients with hematologic
malignancies (41), suggesting a role in leuke-
mogenesis. The role ofhMSH3 in radiosensi-
tivity is still unclear; it could be through
involvement in transcription-coupled repair
of both ultraviolet- and ionizing-radiation-
induced DNA damage. This mechanism
requires genes involved in DNA mismatch
repair (42).
Although prenatal X rays are considered a
causal factor for ALL (1), the role ofpostnatal
X rays is typically not considered a causal fac-
tor for ALL. A recent review ofthe effects of
ionizing radiation on cancer risk from an epi-
demiologic perspective does not include results
on postnatal diagnostic X rays (43). On the
other hand, uncertainty toward dose control
in pediatric X rays, greater susceptibility of
children (28), and the results in thisstudymay
be sufficient tojustify otherstudies.
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